Тема статьи

Авторы

Джаббаров З.И.

Учреждение

Бухарский филиал Республиканского научного центра неотложной скорой помощи

Аннотация

В этом обзоре мы обобщили современное понимание конкретных микроэлемен-тов и их связи с хроническими заболеваниями печени.

Ключевые слова

печень, микроэлементы, железо, селен, цинк, магний, морфология.

Литературы

1. Berger MM, Shenkin A, Schweinlin A, Amrein K, Augsburger M, Biesalski HK, et al. ESPEN micronutrient guideline. Clin Nutr. 2022;41(6):1357–424. https://doi.org/10.1016/j.clnu.2022.02.015.
2. Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020;39(12):3533–62. https://doi.org/10.1016/j. clnu.2020.09.001.
3. Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Data-base Syst Rev. 2021;2021(10). https://doi.org/10.1002/ 14651858.cd011564.pub3.
4. Blaner WS. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacol Ther. 2019;197:153– 78. https://doi.org/10.1016/j.pharmthera.2019.01.006
5. Bloom A, Bloom S, Silva H, Nicoll AJ, Sawhney R. Zinc supplementation and its bene-fits in the management of chronic liver disease: an in-depth literature review. Ann Hepatol. 2021;25:100549. https://doi.org/10.1016/j.aohep.2021.100549.
6. Carvalho L, Parise ER. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol. 2006;43(4):269– 74. https://doi.org/10.1590/s0004-28032006000400005.
7. Cheung K, Lee SS, Raman M. Preva-lence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol. 2012;10(2):117–25. https://doi.org/10.1016/j.cgh.2011.08.016.
8. Diglio DC, Fernandes SA, Stein J, Azeredo-da-Silva A, de Mattos AA, Tovo CV. Role of zinc supplementation in the management of chronic liver diseases: a systematic re-view and meta-analysis. Ann Hepatol. 2020;19(2):190–6. https:// doi.org/10.1016/j.aohep.2019.08.011.
9. Fang A, Zhu H. Serum copper and zinc levels and risk of hepatocellular carcinoma: a 1:1 matched case-control study. Curr Dev Nutr. 2020;4:nzaa061_25. https://doi.org/10.1093/cdn/nzaa061_025.
10. Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O. Low 25-Hydroxyvitamin D levels are associated with infections and mortality in patients with cirrhosis. PLOS ONE. 2015;10(6): e0132119. https://doi.org/10.1371/journal.pone.0132119.
11. Gad AI, Elmedames MR, Abdelhai AR, Marei AM. The association between vitamin D status and non-alcoholic fatty liver disease in adults: a hospital-based study. Egypt Liver J. 2020;10(1). https://doi.org/10.1186/s43066-020-00033-z.
12. Gaussin V, Gailly P, Gillis JM, Hue L. Fructose-induced increase in intracellular free Mg2+ ion concentration in rat hepatocytes: relation with the enzymes of glycogen metabolism. Biochem J 1997; 326: 823-827 [PMID: 9307033 DOI: 10.1042/bj3260823]
13. Grover I, Gunjan D, Singh N, Benja-min J, Ramakrishnan L, Pandey RM, et al. Effect of vitamin D supplementation on vitamin D level and bone mineral density in patients with cirrhosis: a randomized clinical trial. Am J Gastroenterol. 2021;116(10):2098– 104. https://doi.org/10.14309/ajg.0000000000001272.
14. Grüngreiff K, Reinhold D, Wedemeyer H. The role of zinc in liver cirrhosis. Ann Hepatol. 2016;15(1):7–16. https://doi.org/10.5604/16652681.1184191.
15. Jacobs ET, Lance P, Mandarino LJ, Ellis NA, Chow HHS, Foote J, et al. Selenium supplementation and insulin resistance in a randomized, clinical trial. BMJ Open Diabetes Res Care. 2019;7(1):e000613. https://doi.org/10.1136/ bmjdrc-2018-000613.
16. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5: i3-i14 [PMID: 26069819 DOI: 10.1093/ndtplus/sfr163]
17. Kataria Y, Deaton RJ, Enk E, Jin M, Petrauskaite M, Dong L, et al. Retinoid and ca-rotenoid status in serum and liver among patients at high-risk for liver cancer. BMC Gastroenterol. 2016;16(1). https://doi.org/10.1186/s12876-016-0432-5.
18. Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An argument for vitamin D, A, and sinc monitoring in cirrhosis. Ann Hepatol. 2018;17(6):920–32. https://doi.org/10.5604/01.3001.0012.7192.
19. Kubesch A, Quenstedt L, Saleh M, Rüschenbaum S, Schwarzkopf K, Martinez Y, et al. Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: a prospective cohort study. PLOS ONE. 2018;13(11):e0207162. https://doi.org/10.1371/journal.pone.0207162.
20. Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama G, et al. Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight junction proteins and barrier function in F9 cells during visceral endodermal differentiation. Exp Cell Res. 2001;263(1):163–72. https://doi.org/10.1006/excr.2000.5113.
21. L, et al. Mortality risk factors among patients with cirrhosis and a low model for end-stage liver disease sodium score (≤15): an analysis of liver transplant allocation policy using aggregated electronic health record data. Am J Transplant. 2017;17(9):2410–9. https://doi.org/10.1111/ajt.14239.
22. Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatolo-gy. 2021;74(3):1611–44. https://doi.org/10.1002/hep.32049
23. Licata A, Zerbo M, Como S, Cammilleri M, Soresi M, Montalto G, et al. The role of vitamin deficiency in liver disease: to supplement or not supplement? Nutrients. 2021;13(11):4014. https://doi.org/10.3390/nu13114014.
24. Lin Y, He F, Lian S, Xie B, Liu T, He J, et al. Selenium status in patients with chronic liver disease: a systematic review and meta-analysis. Nutrients. 2022;14(5):952. https://doi.org/10. 3390/nu14050952.
25. Llibre-Nieto G, Lira A, Vergara M, Solé C, Casas M, Puig-Diví V, et al. Micronutrient deficiencies in patients with decompensated liver cirrhosis. Nutrients. 2021;13(4):1249. https://doi.org/10.3390/nu13041249
26. Merli M, Giusto M, Gentili F, Novelli G, Ferretti G, Riggio O, et al. Nutritional status: its influence on the outcome of patients under-going liver transplantation. Liver Int. 2010;30(2):208–14. https://doi.org/10.1111/j.1478-3231.2009.02135.x.
27. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? Hepatology. 1996;23(5):1041–6. https://doi.org/ 10.1002/hep.510230516
28. Mohamed AA, Al-Karmalawy AA, El-Kholy AA, El-Damas DA, Abostate HM, Mosta-fa SM, et al. Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized con-trolled study. Eur Rev Med Pharmacol Sci. 2021;25(22):6908–19. https://doi.org/10.26355/eurrev_202111_27239..
29. Nishikawa H, Asai A, Fukunishi S. The significance of zinc in patients with chronic liver disease. Nutrients. 2022;14(22):4855. https://doi.org/10.3390/nu14224855.
30. Ordak M, Maj-Zurawska M, Matsu-moto H, Bujalska-Zadrozny M, Kieres-Salomonski I, Nasierowski T, Muszynska E, Wojnar M. Ionized magnesium in plasma and erythrocytes for the assessment of low magnesium status in alcohol dependent patients. Drug Alcohol Depend 2017; 178: 271-276 [PMID: 28683422 DOI: 10.1016/j.drugalcdep.2017.04.035]
31. Paternostro R, Wagner D, Reiberger T, Mandorfer M, Schwarzer R, Ferlitsch M, et al. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis. Wien Klin Woch-enschr. 2017;129(1–2):8–15. https://doi.org/10.1007/s00508-016-1127-1.
32. Perumpail B, Li A, John N, Sallam S, Shah N, Kwong W, et al. The role of vitamin E in the treatment of NAFLD. Diseases. 2018;6(4):86. https://doi.org/10.3390/diseases6040086.
33. Reja M, Makar M, Visaria A, Marino D, Rustgi V. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Surve (NHANES) III. Ann Hepatol. 2020;19(6):635–40. https://doi. org/10.1016/j.aohep.2020.07.006. Third Nation-al Health and
34. Romani AM, Scarpa A. Regulation of cellular magnesium. Front Biosci 2000; 5: D720-D734 [PMID:10922296 DOI: 10.2741/romani]
35. Rylander R, Mégevand Y, Lasserre B, Amstutz W, Granbom S. Moderate alcohol consumption and urinary excretion of magnesium and calcium. Scand J Clin Lab Invest 2001; 61: 401-405 [PMID: 11569488 DOI: 10.1080/003655101316911459]
36. Saeed A, Bartuzi P, Heegsma J, Dek-ker D, Kloosterhuis N, De Bruin A, et al. Im-paired hepatic vitamin A metabolism in NAFLD mice leading to vitamin A accumulation in hepatocytes. Cell Mol Gastroenterol Hepatol. 2021;11(1):309-25.e3. https://doi.org/10.1016/j.jcmgh.2020.07.006.
37. Schomburg L, Schweizer U, Köhrle J. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci. 2004;61(16):1988–95. https://doi.org/10.1007/ s00018-004-4114-z.
38. Shi Z, Abou-Samra AB. Association of low serum magnesium with diabetes and hypertension: Findingsfrom Qatar Biobank study. Diabetes Res Clin Pract 2019; 158: 107903 [PMID: 31678625 DOI: 10.1016/j.diabres.2019.107903]
39. Shih C-W, Chen Y-J, Chen W-L. Inverse association between serum selenium level and severity of liver fibrosis: a cross-sectional study. Nutrients. 2022;14(17):3625. https://doi.org/10. 3390/nu14173625.
40. Simbrunner B, Semmler G, Stadlmann A, Scheiner B, Schwabl P, Paternostro R, et al. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis. Hep Intl. 2020;14(6):1093–103. https://doi.org/10.1007/s12072-020-10112-3.
41. Song J, Jiang ZG. Low vitamin A levels are associated with liver-related mortality: a nationally representative cohort study. Hepatol Commun. 2023;7(5). https://doi.org/10.1097/hc9.00000 00000000124. A large cohort study demonstrating the association between retinol deficiency and liver fibrosis and liverrelated mortality.
42. Steinbrenner H, Duntas LH, Rayman MP. The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. Redox Biol. 2022;50:102236. https://doi.org/10.1016/j.redox.2022.102236.
43. Stokes CS, Krawczyk M, Reichel C, Lammert F, Grünhage F. Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis. Eur J Clin Invest. 2014;44(2):176– 83. https://doi.org/10.1111/eci.12205.
44. Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol. 2008;23(4):527– 33. https://doi.org/10.1111/j.1440-1746.2008.05369.x.
45. Young A, Cefaratti C, Romani A. Chronic EtOH administration alters liver Mg2+ homeostasis. Am J Physiol Gastrointest Liver Physiol 2003; 284: G57-G67 [PMID: 12488234 DOI: 10.1152/ajpgi.00153.2002] Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, Vanwagner
46. Zafar MS, Wani JI, Karim R, Mir MM, Koul PA. Significance of serum magnesium levels in critically ill patients. Int J Appl Basic Med Res 2014; 4: 34-37 [PMID: 24600576 DOI: 10.4103/2229-516X.125690]
47. Zhang Z, Wu L, Wang G, Hu P. Effect of vitamin D deficiency on spontaneous peritonitis in cirrhosis: a meta-analysis.220 Current Hepatology Reports (2023) 22:216–220 1 3 Gastroenterol Rev. 2021;16(1):10–4. https://doi.org/10.5114/pg. 2020.101632